Arena Pharmaceuticals Inc...

NASDAQ: ARNA · Real-Time Price · USD
99.99
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Arena Pharmaceuticals Revenue Breakdown

Period Ending Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Collaboration And Other Revenue Revenue 54K 57K 800M
Collaboration And Other Revenue Revenue Growth -5.26% -99.99% n/a
License Revenue n/a n/a 7.28M
License Revenue Growth n/a n/a n/a
Royalty Revenue n/a n/a n/a
Royalty Revenue Growth n/a n/a n/a

Operating Expense Breakdown

Period Ending Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 34.5M 30.3M 31.9M 29.5M 34.9M 19M 22.9M 26.4M 22.2M 20.4M 18.4M 16.6M 15.4M 10.8M 10.4M 11.2M 7.1M 7.8M 7.2M 8.2M 7.2M 8.6M 8.5M 6.9M 9.7M 9M 8.8M 8.4M
Selling, General, and Administrative Revenue Growth +13.86% -5.02% +8.14% -15.47% +83.68% -17.03% -13.26% +18.92% +8.82% +10.87% +10.84% +7.79% +42.59% +3.85% -7.14% +57.75% -8.97% +8.33% -12.20% +13.89% -16.28% +1.18% +23.19% -28.87% +7.78% +2.27% +4.76% n/a
Research and Development Revenue 110.34M 94.18M 112.45M 102.53M 100.44M 79.82M 64.95M 78.53M 74.63M 60.26M 51.21M 45.4M 37.89M 28.81M 26.75M 21.57M 20.25M 17.31M 17.92M 15.51M 11.91M 17.47M 18.55M 18.5M 20.17M 22.07M 24.2M 21.97M
Research and Development Revenue Growth +17.16% -16.25% +9.67% +2.08% +25.83% +22.90% -17.30% +5.23% +23.86% +17.66% +12.81% +19.81% +31.51% +7.68% +24.02% +6.54% +16.99% -3.43% +15.54% +30.22% -31.80% -5.82% +0.24% -8.27% -8.62% -8.80% +10.16% n/a